Biological E

Biological E, established in 1953, is a prominent biotechnology and pharmaceutical company based in India. Specializing in critical vaccines and pharmaceutical products, the company plays a vital role in public health initiatives, notably as an active partner in India's National Immunization Program. Its operations span across the healthcare sector, focusing on developing and manufacturing essential biologicals and pharmaceutical ingredients. With a history rooted in scientific advancement, Biological E has built a reputation for quality and reliability in the global pharmaceutical landscape.

The company operates with a workforce of 1,000-5,000 employees across its four locations, demonstrating significant operational capacity. Biological E's product portfolio includes a range of vaccines, active pharmaceutical ingredients, and other biological products designed to address diverse medical needs. Their commitment to innovation is evident in their continuous efforts to expand their offerings and improve existing formulations. For insights into the people driving these advancements, one can explore Meet Biological E's team. This focus on human capital complements their technological infrastructure and research capabilities.

Financially, Biological E reported a substantial revenue of $693.7M, underscoring its market presence and economic impact. The company has also secured strategic funding, including a $5M grant from the Coalition for Epidemic Preparedness Innovations (CEPI) in 2020, supporting its vaccine development efforts. This financial backing, combined with its operational scale and product diversity, positions Biological E as a key player in the biotechnology and pharmaceutical industries. Further details on its financial performance are available via Explore financial highlights. The company leverages its expertise in healthcare and biotechnologyView more...